Pretargeted Radioimmunotherapy in Metastatic Colorectal Cancer

Study ID
NCT02300922

Study type
Interventional

Study phase
Phase 1/Phase 2

Study status
Terminated

Trial Acronym

RITCOLON

Trial Summary

Phase I/II, Open-labeled, Prospective, Multi-center study of a Pretargeted Radioimmunotherapy in metastatic colorectal cancer with ractionated injections of TF2 plus 90Y-IMP288 (RITCOLON).

More informations

Trial Starting Date

Jan 27,2015

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit